Bio Nova International is the leading biosynthetic tissue manufacturer in the world, specialising in collagen based medical devices. Bio Nova’s proprietary technology is founded on three dimensional collagen based structures (“tissue scaffolds”) for use in implantable medical devices for the treatment of defective tissues and organs.
Bio Nova produces Omniflow II vascular prostheses and sells the product range via its global network of distribution partners in over 30 countries worldwide.
Omniflow II is a biosynthetic vascular prosthesis (graft) with a unique composit…
Supplied by Bio Nova International
Omniflow II is a biosynthetic vascular prosthesis (graft) with a unique composite structure of collagen and polyster mesh.
Omniflow II vascular prostheses and patches are used by surgeons for surgical bypass of diseased peripheral arteries to avoid amputation, for arteriovenous access (AV access) in haemodialysis patients, and for repair of damaged blood vessels.
Omniflow II offers distinct clinical advantages in terms of higher patency and higher resistance to infection compared to synthetic grafts.
Omniflow II is CE marked and also approved for use by regulatory agencies in various other countries. It is a premium product offering premium performamce.
Current export locations:
Regions we are wishing to develop export opportunities within:
Most Australian businesses are currently operating - it is 2:05pm on Friday in Victoria.